Benzinga - Gainers
- Jeffs' Brands Ltd (NASDAQ: JFBR) rose 76.5% to $2.70 in pre-market trading after jumping 19% on Friday.
- Pliant Therapeutics, Inc. (NASDAQ: PLRX) rose 48.8% to $33.49 in pre-market trading after the company announced data from the integris-IPF Phase 2a trial demonstrating bexotegrast 320 mg was well tolerated and achieved statistically significant FVC increase in patients with idiopathic pulmonary fibrosis.
- Helbiz, Inc. (NASDAQ: HLBZ) rose 46.9% to $0.2993 in pre-market trading. Helbiz shares jumped 65% on Friday after the company said its Board of Directors has begun examining measures to address alleged illegal short selling of its stock.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 35.9% to $0.3450 in pre-market trading after gaining over 16% on Friday. Allarity Therapeutics announced adjournment of 2023 annual meeting of stockholders.
- Boxed, Inc. (NYSE: BOXD) shares rose 34.3% to $0.6351 in pre-market trading after the company reported up to $20 million of new financing.
- Genius Group Limited (NYSE: GNS) shares rose 22.2% to $3.96 in pre-market trading. Genius Group shares jumped 55% on Friday on continued strength after the company approved a plan to create an 'Illegal Trading Task Force.'
- WiSA Technologies, Inc. (NASDAQ: WISA) rose 13.6% to $0.16 in pre-market trading after jumping 14% on Friday.
- Digital Brands Group, Inc. (NASDAQ: DBGI) shares rose 10.6% to $2.85 in pre-market trading. DBG recently announced closing of $5.0 million private placement priced at-the-market under Nasdaq rules.
- Exela Technologies, Inc. (NASDAQ: XELA) rose 7.4% to $0.0799 in pre-market trading. Exela Technologies recently signed a strategic partnership with Quintes Global.
- Tritium DCFC Limited (NASDAQ: DCFC) rose 5.3% to $1.38 in pre-market trading. The company recently reported FY22 preliminary sales of $95 million to $102 million.
- Apexigen, Inc. (NASDAQ: APGN) fell 12% to $1.76 in pre-market trading. Apexigen recently announced new Phase 2 data evaluating sotigalimab, its CD40 agonist antibody, at ASCO Gastrointestinal Cancers Symposium 2023.
- Cosmos Health Inc. (NASDAQ: COSM) shares fell 10.8% to $4.75 in pre-market trading. Cosmos Health shares jumped 72% on Friday after the company updated the payment terms of its agreement to acquire ZipDoctor.
- Eargo, Inc. (NASDAQ: EAR) fell 9.7% to $13.13 in pre-market trading after jumping 26% on Friday. The company recently effected a 1:20 reverse stock split.
- Ontrak, Inc. (NASDAQ: OTRK) fell 8.5% to $0.97 in pre-market after declining around 12% on Friday. Ontrak recently announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
- TC Biopharm (Holdings) Plc (NASDAQ: TCBP) fell 7.3% to $4.26 in pre-market trading after dropping around 12% on Friday. TC BioPharm recently received a notice of non-compliance with NASDAQ's Listing Rule 5550(b)(1).
- AppHarvest, Inc. (NASDAQ: APPH) fell 6.2% to $1.52 in pre-market trading after jumping over 16% on Friday. AppHarvest said on January 11, that it received notice from Nasdaq that the company has not been in compliance with minimum bid price requirement.
- OceanPal Inc. (NASDAQ: OP) shares dropped 6.1% to $0.8830 in pre-market trading. OceanPal recently regained compliance with Nasdaq minimum bid price requirement.
- Rigetti Computing, Inc. (NASDAQ: RGTI) fell 5.9% to $0.84 in pre-market trading.
- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares fell 4.5% to $1.70 in pre-market trading after dipping around 20% on Friday. NeuroSense Therapeutics recently reported final results from its Alzheimer's biomarker study.
- Grom Social Enterprises, Inc. (NASDAQ: GROM) fell 4.1% to $1.65 in pre-market trading after gaining 6% on Friday.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.